
<(From Left) Professor Hyunjoo Jenny Lee, Dr.Sang-Mok Lee, Ph.D candidate Xiaojia Liang>
Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them unsuitable for high-resolution imaging or therapeutic applications. A KAIST research team has now overcome these challenges by developing a flexible ultrasound sensor with statically adjustable curvature. This breakthrough opens new possibilities for wearable medical devices that can capture precise, body-conforming images and perform noninvasive treatments using ultrasound energy.
KAIST (President Kwang Hyung Lee) announced on November 12 that a research team led by Professor Hyunjoo Jenny Lee from the School of Electrical Engineering developed a “flex-to-rigid (FTR)” capacitive micromachined ultrasonic transducer (CMUT) capable of transitioning freely between flexibility and rigidity using a semiconductor wafer process (MEMS).
The team incorporated a low-melting-point alloy (LMPA) inside the device. When an electric current is applied, the metal melts, allowing the structure to deform freely; upon cooling, it solidifies again, fixing the sensor into the desired curved shape.
Conventional polymer-membrane-based CMUTs have suffered from a low elastic modulus, resulting in insufficient acoustic power and blurred focal points during vibration. They have also lacked curvature control, limiting precise focusing on target regions.
Professor Lee’s team designed an FTR structure that combines a rigid silicon substrate with a flexible elastomer bridge, achieving both high output performance and mechanical flexibility. The embedded LMPA enables dynamic adjustment and fixation of the transducer’s shape by toggling between solid and liquid states through electrical control.
As a result, the new sensor can automatically focus ultrasound on a specific region according to its curvature—without requiring separate beamforming electronics—and maintains stable electrical and acoustic performance even after repeated bending.

The device’s acoustic output reaches the level of low-intensity focused ultrasound (LIFU), which can gently stimulate tissues to induce therapeutic effects without causing damage. Experiments on animal models demonstrated that noninvasive spleen stimulation reduced inflammation and improved mobility in arthritis models.

In the future, the team plans to extend this technology to a two-dimensional (2D) array structure—arranging multiple sensors in a grid—to enable simultaneous high-resolution ultrasound imaging and therapeutic applications, paving the way for a new generation of smart medical systems.
Because the technology is compatible with semiconductor fabrication processes, it can be mass-produced and adapted for wearable and home-use ultrasound systems.
This study was conducted by Sang-Mok Lee, Xiaojia Liang (co–first authors), and their collaborators under the supervision of Professor Hyunjoo Jenny Lee. The results were published online on October 23 in npj Flexible Electronics (Impact Factor: 15.5).
Paper title: “Flexible ultrasound transducer array with statically adjustable curvature for anti-inflammatory treatment”
DOI: [10.1038/s41528-025-00484-7]
The research was supported by the Bio & Medical Technology Development Program (Brain Science Convergence Research Program) of the Ministry of Science and ICT (MSIT) and the Korea Medical Device Development Fund, a multi-ministerial R&D initiative.
<(From Left) Professor Keon Jae Lee, Professor Tae-Hyuk Kwon, Ph.D candidate Min Seo Kim, Dr. Jae Hee Lee, Dr. Chae Gyu Lee> -KAIST and UNIST Researchers Develop Shape-Morphing Device to Overcome Pancreatic Tumor Microenvironment Barriers Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumor microenvironment (TME). This biological barrier surrounds the tumor, severely limiting the infiltration of chemotherapy agents and immune cells. While photody
2025-12-11<(From Left) Professor Yong Woong Jun, Ph.D candidate Tae Ung Jeong, Ph.D candidate Jihun Choi> mRNA, widely known from the COVID-19 vaccine, is not actually a “therapeutic agent,” but a technology that delivers the blueprint for functional proteins into the body so that induces therapeutic effects. Recently, its application has expanded to cancer and genetic disease treatments, but mRNA therapeutics have caused serious side effects such as pulmonary embolism, stroke, thromb
2025-12-02<(From Left) Professor Ji Tae Kim of the Department of Mechanical Engineering, Professor Soong Ju Oh of Korea University and Professor Tianshuo Zhao of the University of Hong Kong> The “electronic eyes” technology that can recognize objects even in darkness has taken a step forward. Infrared sensors, which act as the “seeing” component in devices such as LiDAR for autonomous vehicles, 3D face recognition systems in smartphones, and wearable healthcare devices, ar
2025-11-03<(From Left) Professor Jeong Ho Lee, CEO Cheolwon Park, Principal Researcher Sang-min Park> KAIST (President Kwang Hyung Lee) announced on the 9th of October that Sovargen (co-led by CEOs Cheolwon Park and Jeong Ho Lee), a faculty startup led by Professor Jeong Ho Lee of the KAIST Graduate School of Medical Science and Engineering, has successfully achieved a global technology export deal worth a total of 750 billion KRW. The deal involves an innovative RNA-based new drug candidate for
2025-10-10<(Front) Ph.D. candidate Jisoo Nam, (Back row, from left) Ph.D. candidate Boxin Chen, Professor Miso Kim> Photocurable 3D printing, widely used for everything from dental treatments to complex prototype manufacturing, is fast and precise but has the limitation of being fragile and easily broken by impact. A KAIST research team has developed a new technology to overcome this weakness, paving the way for the more robust and economical production of everything from medical implants to prec
2025-09-30